Prenatal diagnosis and management of congenital complete heart block

Jay D Pruetz1,2, Jennifer C Miller1,2, Gerald E Loeb3

  • 1Department of Pediatrics/Division of Pediatric Cardiology, Children's Hospital Los Angeles, Los Angeles, California.

Insights

Congenital complete heart block (CCHB) in fetuses is serious, with limited prenatal treatments. New minimally invasive pacemakers offer hope for in-utero management, improving outcomes before birth.

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Pediatric Cardiology

Background:

  • Congenital complete heart block (CCHB) presents significant risks to unborn fetuses, lacking effective prenatal interventions.
  • Current treatments, including maternal medications and anti-inflammatory therapies, offer only marginal benefits and cannot reverse CCHB.
  • Advances in prenatal diagnosis and surveillance have led to minor improvements in fetal morbidity and mortality.

Purpose of the Study:

  • To review current and emerging prenatal interventions for congenital complete heart block.
  • To explore the potential of novel technologies like fetal pacemakers for in-utero management of CCHB.
  • To identify challenges and future directions in managing CCHB during pregnancy.

Main Methods:

  • Review of existing literature on CCHB prenatal management strategies.
  • Analysis of current diagnostic and surveillance protocols for fetal heart block.
  • Evaluation of preliminary data on emerging therapies, including hydroxychloroquine and intrauterine fetal pacing.
  • Discussion of the potential of a fully implantable micropacemaker for fetal intervention.

Main Results:

  • Maternal drug administration and anti-inflammatory therapies show limited efficacy in reversing CCHB but may reduce myocarditis.
  • Improved prenatal diagnosis and surveillance protocols have slightly reduced CCHB-related morbidity and mortality.
  • Intrauterine fetal pacing attempts have been hindered by invasive techniques and lead complications.
  • Preliminary research suggests hydroxychloroquine may have a preventive role, though efficacy and safety require further study.

Conclusions:

  • Effective prenatal interventions for CCHB remain a critical unmet need.
  • Minimally invasive fetal pacemakers represent a promising future strategy for in-utero CCHB management.
  • Further research is essential to develop and validate prenatal interventions to manage CCHB until successful postnatal pacemaker implantation.

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
245
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
272
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
348
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
324
Nursing Diagnosis01:22

Nursing Diagnosis

Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
4.0K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
553